Pancreatic Cancer Research

ResearcherUniversity of Southern CaliforniaActive in the last 2 years

Thomas D. Schmittgen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2812-8546; OpenAlex author ID A5001854674; NIH RePORTER profile ID 8010551. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 7)
Trials
0
Grants
4
Labs led
1
Collaborators
60
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 grant · 2025: 1 paper · 2026: 2 papers, 3 grants

Papers 13

  1. Renin-angiotensin-aldosterone system inhibitors and risk of pancreatic cancer in older adults: A target trial emulation. Co-author DOI 10.1002/ijc.70438↗
  2. Dimensional Priming Reprograms Adipose-Derived Stromal Cells to Promote Pancreatic Cancer Progression. Co-author DOI 10.3390/cancers18030460↗
  3. Nanomaterial isolated extracellular vesicles enable high precision identification of tumor biomarkers for pancreatic cancer liquid biopsy. Co-author DOI 10.1186/s12951-025-03527-3↗
  4. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. Last author DOI 10.1007/s10555-021-09995-x↗
  5. Acinar Cell–Enriched–MicroRNA-802 Connects the Dots Between Kras Signaling, Acinar Ductal Metaplasia, and Pancreatic Cancer Co-author DOI 10.1053/j.gastro.2021.10.011↗
  6. Enhancing African American Participation in Biospecimens: A Case in Point for Pancreatic Cancer. Last author DOI 10.1158/1538-7755.disp20-po-236↗
  7. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer. Last author DOI 10.1038/s41598-019-47566-x↗
  8. Pancreatic Cancer Related Health Disparities: A Commentary. Co-author DOI 10.3390/cancers10070235↗
  9. miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethal. Last author DOI 10.1007/s10142-016-0512-1↗
  10. Expression Profiling Identifies the Noncoding Processed Transcript of HNRNPU with Proliferative Properties in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ncrna3030024↗
  11. Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Last author DOI 10.18632/oncotarget.10242↗
  12. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-013-3240-y↗
  13. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Last author DOI 10.1016/j.bbrc.2011.02.065↗

Grants 4

  1. Community Outreach Core U54CA233396↗
  2. Community Outreach Core U54CA233444↗
  3. Community Outreach Core (COC) U54CA233465↗
  4. NCI Diversity Supplement R21CA277263↗

Closest collaborators

The 25 strongest of 60 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Romonia Renee REAMS · 2 shared grants, 2026 · strength 1.11
  2. Bo Han · 1 shared paper, 1 shared grant, 2026 · strength 0.96
  3. Fan Zhang · 1 shared grant, 2024 · strength 0.91
  4. Jinmai Jiang · 7 shared papers, 2011–2026 · strength 0.83
  5. Veronica Wendy Setiawan · 2 shared papers, 1 shared grant, 2018–2026 · strength 0.82
  6. Tianze Jiao · 1 shared paper, 1 shared grant, 2026 · strength 0.75
  7. Edward Agyare · 1 shared paper, 1 shared grant, 2018–2026 · strength 0.70
  8. Hernan Alcides Flores-Rozas · 1 shared grant, 2026 · strength 0.63
  9. Gebre-Egziabher Kiros · 1 shared grant, 2026 · strength 0.63
  10. Jamel Ali · 1 shared grant, 2026 · strength 0.63
  11. Eun Lee · 1 shared grant, 2026 · strength 0.63
  12. Sandra G Suther · 1 shared grant, 2026 · strength 0.63
  13. Enrique Israel Velazquez Villarreal · 1 shared grant, 2026 · strength 0.60
  14. Wendy Cozen · 1 shared grant, 2026 · strength 0.60
  15. Bo Han · 1 shared grant, 2026 · strength 0.60
  16. Bodour Salhia · 1 shared grant, 2026 · strength 0.60
  17. Lourdes A. Baezconde-Garbanati · 1 shared grant, 2026 · strength 0.60
  18. Jennifer Tsui · 1 shared grant, 2026 · strength 0.60
  19. Jose Gilberto Trevino · 1 shared paper, 1 shared grant, 2018–2026 · strength 0.55
  20. Folakemi T Odedina · 1 shared paper, 1 shared grant, 2018–2026 · strength 0.55
  21. Yingwei Yao · 1 shared grant, 2026 · strength 0.48
  22. Ernest Kaninjing · 1 shared grant, 2026 · strength 0.48
  23. Sherise Chantell Rogers · 1 shared grant, 2026 · strength 0.48
  24. Rodrigo Cristofoletti · 1 shared grant, 2026 · strength 0.48
  25. Kinfe Ken Redda · 1 shared grant, 2026 · strength 0.48

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.